Immunogen reported $0 in Debt for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Debt Change
Abbvie ABBV:US $ 73474M 3210M
Agios Pharmaceuticals AGIO:US $ 0.53M 0.08M
Amgen AMGN:US $ 36854M 3545M
Astellas Pharma 4503:JP Y 280850M 29394M
AstraZeneca AZN:LN 31099M 318M
Bluebird Bio BLUE:US $ 0M 0M
Bristol Myers Squibb BMY:US $ 44972M 419M
Cerulean Pharma CERU:US $ 0M 0M
Eli Lilly And LLY:US $ 16508.8M 375.9M
Emergent Biosolutions EBS:US $ 833.1M 7.9M
Exelixis EXEL:US $ 0M 0M
Halozyme Therapeutics HALO:US $ 877.64M 0.97M
Heron Therapeutics HRTX:US $ 149.13M 0.05M
Immunogen IMGN:US $ 0M 0M
Intrexon XON:US $ 201.47M 18.32M
Karyopharm Therapeutics KPTI:US $ 302.49M 198K
Macrogenics MGNX:US $ 0M 0M
Nektar Therapeutics NKTR:US $ 0M 0M
Novartis NVS:US $ 31275M 250M
Pfizer PFE:US $ 36301M 2135M
Regeneron Pharmaceuticals REGN:US $ 2700.4M 0.7M
Seattle Genetics SGEN:US $ 0M 0M